1,2-cyclohexanediamine has been researched along with Auricular Fibrillation in 1 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, S | 1 |
| Camm, JA | 1 |
| Harald, D | 1 |
| Steffel, J | 1 |
| Virdone, S | 1 |
| Pieper, K | 1 |
| Brodmann, M | 1 |
| Schellong, S | 1 |
| Misselwitz, F | 1 |
| Kayani, G | 1 |
| Kakkar, AK | 1 |
1 other study available for 1,2-cyclohexanediamine and Auricular Fibrillation
| Article | Year |
|---|---|
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Humans; Registries; Risk Factors | 2023 |